Results 51 to 60 of about 424,860 (186)
Adatátvitel QUIC protokoll alapokon
A szakdolgozat célja egy fájlátviteli program megírása QUIC protokollal az FMFT+ projekt részeként. A dolgozat első része a TCP és UDP protokoll történetét és működését vizsgálja. Részletezi a QUIC-et mint UDP alapú protokollt.
Beliczky, Zsolt Péter
core
RT-QuIC titration of ScBH treated with BrioHOCl with increasing available Cl.
RT-QuIC titration of ScBH treated with BrioHOCl with increasing available Cl.
Bradley R. Groveman (756802) +14 more
core +1 more source
Aggregated α-synuclein (αSyn) protein is a core pathological feature of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Both PD and DLB demonstrate the presence of diverse intracellular α-synuclein (αSyn) species, including C-terminally ...
Ilaria Poggiolini +6 more
doaj +1 more source
RT-QuIC analysis of water or bleach treated CWD-positive brain homogenates.
A 10% brain homogenate of WTD-1 was mixed with 9 volumes of either water, 1%, or 10% bleach for 1 minute. Following treatment, the samples were diluted in RT-QuIC buffer to a 10−4 brain homogenate dilution and tested by RT-QuIC.
Katie Williams (6166097) +3 more
core +1 more source
10%BH seeded RT-QuIC reaction kinetics and PK resistant RT-QuIC reaction products.
A) Averaged RT-QuIC traces per individual seed are displayed along with the number of replicates that reached the fluorescence threshold for positivity.
Gabriele Piconi (6848594) +3 more
core +1 more source
A noninvasive test for human prion disease using hair roots and scalp
Invasive tests like cerebrospinal fluid (CSF) examination are highly effective for diagnosing human prion disease (HPD). Real-time quaking-induced conversion (RT-QuIC) CSF assay demonstrates 80–90% sensitivity for HPD diagnosis.
Thi-Thu-Trang Dong +29 more
doaj +1 more source
Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin +8 more
wiley +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease
Objective Positive α‐synuclein seed amplification assay (SAA) is a biomarker found in most people with Parkinson's disease (PD). We explored if free‐water (FW) imaging detects microstructural differences in the brains of patients with early PD with SAA+ or SAA– status.
Shannon Y. Chiu +145 more
wiley +1 more source

